Veronique Guyonnet-Duperat
Overview
Explore the profile of Veronique Guyonnet-Duperat including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
25
Citations
581
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Boutin J, Genevois C, Couillaud F, Lamrissi-Garcia I, Guyonnet-Duperat V, Bibeyran A, et al.
Mol Ther Oncol
. 2024 Apr;
32(1):200772.
PMID: 38596305
Thanks to its very high genome-editing efficiency, CRISPR-Cas9 technology could be a promising anticancer weapon. Clinical trials using CRISPR-Cas9 nuclease to edit and alter immune cells are ongoing. However, to...
2.
Lapaillerie D, Charlier C, Guyonnet-Duperat V, Murigneux E, Fernandes H, Martins F, et al.
Antimicrob Agents Chemother
. 2022 Jul;
66(8):e0008322.
PMID: 35861550
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the infectious agent that has caused the current coronavirus disease (COVID) pandemic. Viral infection relies on the viral S (spike) protein/cellular receptor...
3.
Dard L, Hubert C, Esteves P, Blanchard W, Bou About G, Baldasseroni L, et al.
J Clin Invest
. 2022 Mar;
132(8).
PMID: 35230976
Germline mutations that activate genes in the canonical RAS/MAPK signaling pathway are responsible for rare human developmental disorders known as RASopathies. Here, we analyzed the molecular determinants of Costello syndrome...
4.
Lapaillerie D, Charlier C, Fernandes H, Sousa S, Lesbats P, Weigel P, et al.
Viruses
. 2021 Mar;
13(3).
PMID: 33669132
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiologic agent responsible for the recent coronavirus disease 2019 (COVID-19) pandemic. Productive SARS-CoV-2 infection relies on viral entry into cells expressing...
5.
Dias Amoedo N, Sarlak S, Obre E, Esteves P, Begueret H, Kieffer Y, et al.
J Clin Invest
. 2021 Jan;
131(1).
PMID: 33393495
Metabolic reprogramming is a common hallmark of cancer, but a large variability in tumor bioenergetics exists between patients. Using high-resolution respirometry on fresh biopsies of human lung adenocarcinoma, we identified...
6.
Capdevielle C, Desplat A, Charpentier J, Sagliocco F, Thiebaud P, Theze N, et al.
Neuro Oncol
. 2019 Nov;
22(4):550-562.
PMID: 31711240
Background: Diffuse midline glioma (DMG) is a pediatric malignancy with poor prognosis. Most children die less than one year after diagnosis. Recently, mutations in histone H3 have been identified and...
7.
Cario M, Pain C, Kaulanjan-Checkmodine P, Masia D, Delia G, Casoli V, et al.
Pigment Cell Melanoma Res
. 2019 Nov;
33(3):435-445.
PMID: 31692218
Human skin melanin pigmentation is regulated by systemic and local factors. According to the type of melanin produced by melanocytes, the transfer and degradation of melanosomes differ, thus accounting for...
8.
Hosseini M, Rezvani H, Aroua N, Bosc C, Farge T, Saland E, et al.
Cancer Res
. 2019 Jul;
79(20):5191-5203.
PMID: 31358527
Chemotherapies alter cellular redox balance and reactive oxygen species (ROS) content. Recent studies have reported that chemoresistant cells have an increased oxidative state in hematologic malignancies. In this study, we...
9.
Cullot G, Boutin J, Toutain J, Prat F, Pennamen P, Rooryck C, et al.
Nat Commun
. 2019 Mar;
10(1):1136.
PMID: 30850590
CRISPR-Cas9 is a promising technology for genome editing. Here we use Cas9 nuclease-induced double-strand break DNA (DSB) at the UROS locus to model and correct congenital erythropoietic porphyria. We demonstrate...
10.
Bedel A, Beliveau F, Lamrissi-Garcia I, Rousseau B, Moranvillier I, Rucheton B, et al.
Stem Cells Transl Med
. 2017 Feb;
6(2):382-393.
PMID: 28191782
Iatrogenic tumorigenesis is a major limitation for the use of human induced pluripotent stem cells (hiPSCs) in hematology. The teratoma risk comes from the persistence of hiPSCs in differentiated cell...